CELEX: 62021TN0477
Language: en
Date: 2021-08-09 00:00:00
Title: Case T-477/21: Action brought on 9 August 2021 — Glaxo Group v EUIPO — Cipla Europe (Shape of an inhaler)

20.9.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 382/34
            
         
      Action brought on 9 August 2021 — Glaxo Group v EUIPO — Cipla Europe (Shape of an inhaler)
      (Case T-477/21)
      (2021/C 382/47)
      Language of the case: English
      
         Parties
      
      
         Applicant: Glaxo Group Ltd (Brentford, United Kingdom) (represented by: T. de Haan and F. Verhoestraete, lawyers)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Cipla Europe NV (Antwerp, Belgium)
      
         Details of the proceedings before EUIPO
      
      
         Proprietor of the trademark at issue: Applicant before the General Court
      
         Trade mark at issue: European Union tridimensional mark (Shape of an inhaler) — European Union trade mark No 2 179 562
      
         Procedure before EUIPO: Cancellation proceedings
      
         Contested decision: Decision of the First Board of Appeal of EUIPO of 19 May 2021 in Case R 1835/2016-1
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  set aside the contested decision;
               
            
                  —
               
               
                  order EUIPO and the intervener to bear the costs, including those incurred by the applicant before the Office’s First Board of Appeal.
               
            
         Pleas in law
      
      
                  —
               
               
                  Infringement of Articles 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council and 41(2) of the Charter of Fundamental Rights of the EU;
               
            
                  —
               
               
                  Infringement of Article 7(1)(b) of Council Regulation (EC) 40/94;
               
            
                  —
               
               
                  Infringement of Article 52(2) of Council Regulation (EC) 207/2009.